Acts and Regulations

2008-54 - Designated Materials

Section 50.82
Disposition versions

Full text
Annual report and other information
2022-73
50.82(1)On or before April 30 in each year, a brand owner shall provide the Board with an annual report detailing the effectiveness of the pharmaceutical products and medical sharps stewardship plan during the previous calendar year including, but not limited to, the following:
(a) the total amount of pharmaceutical product and medical sharp waste, by material type,
(i) collected within the Province, and
(ii) collected within the geographical areas specified in the stewardship plan;
(b) the total amount of pharmaceutical product and medical sharp waste, by material type, processed or in storage;
(c) the amount and percentage of pharmaceutical product and medical sharp waste, by material type, collected that was recycled, recovered for energy, contained, or otherwise treated or disposed of;
(d) a description of the types of processes utilized to recycle, recover energy from, contain, or otherwise treat or dispose of, pharmaceutical product and medical sharp waste, by material type;
(e) a description of collection methods used and, if applicable, the location of return facilities;
(f) the location of any processing or containment facilities for pharmaceutical product and medical sharp waste;
(g) the types of consumer information, educational materials and strategies adopted by the brand owner;
(h) the annual financial statements, as prepared by an independent auditor, of the revenues received and the expenditures incurred by the stewardship plan;
(i) an assessment of the performance of the brand owner’s stewardship plan that is prepared by an independent auditor; and
(j) any other information requested by the Board that relates to the stewardship plan.
50.82(2)Subject to subsection (3), at the same time a brand owner submits its annual report, it shall provide to the Board a statement in writing as to the total amount of pharmaceutical products and medical sharps, by material type, distributed by it during the previous calendar year or during a period of time approved by the Board.
50.82(3)If a report referred to in subsection (1) or a statement referred to in subsection (2) is submitted by an agent referred to in section 50.74, the report or statement and distribution information shall include only the aggregate information of all of the brand owners represented by the agent.
50.82(4)The information provided under subsection (2) to the Board by a brand owner who is not represented by an agent referred to in section 50.74 shall be treated as confidential.
2022-73